perio pathogenesis
DESCRIPTION
periodontologyTRANSCRIPT
-
1Massimo Costalonga D.M.D., Ph.D.Department of Developmental
and Surgical Sciences
Massimo Costalonga D.M.D., Ph.D.Department of Developmental
and Surgical Sciences
Pathogenesis of PeriodontitisCurrent Thinking
Pathogenesis of PeriodontitisCurrent Thinking
Healthy gingivaHealthy gingiva
Normal gingival sulcusis 2 to 3
millimeters deep
Tooth chrown
Gingiva
Root
Periodontal ligament
Alveolar bone
Advanced periodontitis
Advanced periodontitis
Bleeding Infection of the gingiva Calculus Gingival recession Loss of bone Tooth mobility Halitosis (bad breath)
Bleeding Infection of the gingiva Calculus Gingival recession Loss of bone Tooth mobility Halitosis (bad breath)
Disease that is not reversible but ONLY
controllable
Disease that is not reversible but ONLY
controllable
BackgroundBackgroundPeriodontal diseases: Infectious diseases that results in
chronic inflammation of the soft tissue surrounding the gingival pockets.
Destroys the bone and soft tissue connection between the gingiva and the root of the tooth (Kornman 1987, Suzuki 1988)
Periodontal diseases: Infectious diseases that results in
chronic inflammation of the soft tissue surrounding the gingival pockets.
Destroys the bone and soft tissue connection between the gingiva and the root of the tooth (Kornman 1987, Suzuki 1988)
Massimo Costalonga DMD, PhD DENT5301
-
2Chronic periodontitis is associated with a variety of
bacterial species
Chronic periodontitis is associated with a variety of
bacterial species
Bacteriological and immunological studies implicated a number of subgingival organisms associated with chronic adult periodontitis. (Red, Orange, Green, Purple and Yellow complexes) (Socransky et al. 1997)
In advanced adult periodontitis, gram-negative bacteria may compose 75% of the bacteria (Robertson 1985)
Bacteriological and immunological studies implicated a number of subgingival organisms associated with chronic adult periodontitis. (Red, Orange, Green, Purple and Yellow complexes) (Socransky et al. 1997)
In advanced adult periodontitis, gram-negative bacteria may compose 75% of the bacteria (Robertson 1985)
Modified from Socransky S. et al. 1997
Cultivable microorganisms
Cultivable microorganisms
Do you think we can culture all bacteria in periodontal
pocket ?
Do you think we can culture all bacteria in periodontal
pocket ?
Talk with the person next to you about this NOW
Talk with the person next to you about this NOW
Most microorganisms are uncultivable
Most microorganisms are uncultivable
Kumar PS et al. 2005
Massimo Costalonga DMD, PhD DENT5301
-
316S RNA sequences separated health and disease
16S RNA sequences separated health and disease
Kumar PS et al. 2005
Bacterial challenge
Innate immunity
first
Bacterial biofilm
EpitheliumPMNs
ChemokinesCytokines
Korman KS et al. Periodontology 2000 Vol. 14 1997, 33-53
Initial Gingivitis
Acute inflammation
Initial Gingivitis
Acute inflammation
Korman KS et al. Periodontology 2000 Vol. 14 1997, 33-53
How are these microbes sensed or detected by our
body?
How are these microbes sensed or detected by our
body?
Talk with the person next to you about this NOW
Talk with the person next to you about this NOW
Massimo Costalonga DMD, PhD DENT5301
-
4Neutropenia = Low PMN countsNeutropenia = Low PMN counts
Downloaded from: Carranzas Clinical Periodontology (on 4 August 2006 06:34 PM)
INNATE cellular response
Monocytes/macrophages Neutrophils Natural Killer (NK)
Monocytes/macrophages Neutrophils Natural Killer (NK)
Recognition ofPathogen Associated
Molecular Patterns (PAMPs) by Pattern
Recognition Receptors (PRRs)
PRRs
IL-8 Lipid mediators of inflammationLipid mediators of inflammation
Increase vascular permeabilityIncrease smooth muscle contraction
Increase vascular permeabilityIncrease smooth muscle contraction
Increase smooth muscle contractionIncrease smooth muscle contraction
Massimo Costalonga DMD, PhD DENT5301
-
5Linoleic acid in plasma membraneLinoleic acid in plasma membranePhospholipase C Inhibited by
STEROIDS
Inhibited by NSAID
Lipid mediators ofLipid mediators of
Prostaglandins Thromboxans Leukotrienes
Prostaglandins Thromboxans Leukotrienes
Lipoxins Resolvins Protectins
Lipoxins Resolvins Protectins
Inflammation Resolution
T-cell and B-cell mediated immunity in periodontal tissues
MICROBIAL ADHERENCE
PENETRATION AND
INFECTION
INNATE IMMUNITY
DC and Macrophages
LYMPHOCYTE ACTIVATION
ANTIBODY Activated
MACROPHAGES
Toll-like receptors(TLRs)
Toll-like receptors(TLRs)
Massimo Costalonga DMD, PhD DENT5301
-
6Exogenous pathway
1. Extracellular microorganisms are phagocytosed
2. Destroyed and reduced in peptides
3. Presented to T cells via MHC class II molecules
1. Extracellular microorganisms are phagocytosed
2. Destroyed and reduced in peptides
3. Presented to T cells via MHC class II molecules
T helper cells (CD4+)T helper cells (CD4+)In the
lymph nodesT cells
recognize such
microbial peptides via
the T cell receptorand
In the lymph nodes
T cellsrecognize
such microbial
peptides via the T cell receptorand
T helper 1 (Th1)T helper 1 (Th1)
Interferon-(IFN)
Cell-mediatedimmunity
Interferon-(IFN)
Cell-mediatedimmunity
Interleukin-4(IL-4)
Antibody immunity
Interleukin-4(IL-4)
Antibody immunity
T helper 2 (Th2)T helper 2 (Th2)
Massimo Costalonga DMD, PhD DENT5301
-
7 In individuals resistant to periodontitis, neutrophils and cell-mediated immunity (Th1) limit attachment loss (Page et al. 1997).
Lack of cell-mediated immunity (IL-12, IFN and TNF-) promotes susceptibility to periodontitis (Chapple C. 1998).
Antigen Presenting Cells from patients susceptible to periodontitis may have a bias towards a Th2 response and thereby promoting an ineffective humoral immunity in periodontitis (Fokkema S. 2002).
In individuals resistant to periodontitis, neutrophils and cell-mediated immunity (Th1) limit attachment loss (Page et al. 1997).
Lack of cell-mediated immunity (IL-12, IFN and TNF-) promotes susceptibility to periodontitis (Chapple C. 1998).
Antigen Presenting Cells from patients susceptible to periodontitis may have a bias towards a Th2 response and thereby promoting an ineffective humoral immunity in periodontitis (Fokkema S. 2002).
Immune response and periodontitis in humansImmune response and
periodontitis in humans
T helper 1 cytokine IFNprotects from disease
T helper 2 cytokine IL-4does not protect from disease
T helper 1 cytokine IFNprotects from disease
T helper 2 cytokine IL-4does not protect from disease
Th1 vs. Th2in periodontal disease
Th1 vs. Th2in periodontal disease
WHY ???WHY ???
Cells in Periodontal TissuesCells in Periodontal Tissues
Gingivitis lesion: mainly T helper 1 lymphocytes (Th1)
Periodontitis lesion: mainly activated B cells and plasmacells
Activation of B cells is dependent on T helper 2 lymphocytes (Th2)
Gingivitis lesion: mainly T helper 1 lymphocytes (Th1)
Periodontitis lesion: mainly activated B cells and plasmacells
Activation of B cells is dependent on T helper 2 lymphocytes (Th2)
Massimo Costalonga DMD, PhD DENT5301
-
8 Cytokine production most important IL-1 but also TNF-, IL-6, IL-8, IL-12, IL-15 and chemokines MCP-1 and RANTES
Cytokine-induced alteration of the connective tissue metabolism
Imbalance between collagenases and matrix metalloproteinases (MMPs) activity and collagen synthesis
IL-1 and IL-6 induce fibroblast and osteoclast activation
Cytokine production most important IL-1 but also TNF-, IL-6, IL-8, IL-12, IL-15 and chemokines MCP-1 and RANTES
Cytokine-induced alteration of the connective tissue metabolism
Imbalance between collagenases and matrix metalloproteinases (MMPs) activity and collagen synthesis
IL-1 and IL-6 induce fibroblast and osteoclast activation
Destruction phaseDestruction phase
Osteoclast progenitors express the receptor activator of NF-B (RANK)
Activated T cells express the receptor activator of NF-B Ligand (RANKL)
RANK / RANKL interaction + M-CSF generates Tartarate-Resistant Acid Phosphatase positive (TRAP+) osteoclasts => BONE RESORPTION
Osteoclast progenitors express the receptor activator of NF-B (RANK)
Activated T cells express the receptor activator of NF-B Ligand (RANKL)
RANK / RANKL interaction + M-CSF generates Tartarate-Resistant Acid Phosphatase positive (TRAP+) osteoclasts => BONE RESORPTION
Induction of bone lossInduction of bone loss
RANKRANK
Osteoclast Precursor
Osteoclast Precursor
T cell
T helper 1T helper 1
mRANKLmRANKL sRANKLsRANKL
CD4CD4B220B220 B cell
IgG2aIgG2a
Tissue Macrophage
IFNIFN
Bone
Working ModelWorking Model
Osteoclast Precursor
Osteoclast Precursor
RANKRANK
T cell
T helper 2T helper 2
mRANKLmRANKL sRANKLsRANKL
CD4CD4B220B220 B cell
IgG1, IgA
UNPROTECTIVE
IgG1, IgA
UNPROTECTIVE
IL-4 and IL-10
IL-4 and IL-10
TRAP+Osteoclast
TRAP+Osteoclast
Bone Destruction
+ M-CSF+ M-CSF
Bone
Massimo Costalonga DMD, PhD DENT5301
-
9Induced Protection and Therapeutic Future
Induced Protection and Therapeutic Future
Osteoprotegrin (OPG) is a decoy receptor that binds membrane bound and soluble RANKL on activated T and B cells
Potassium channel blocker (Kaliotoxin) reduce the expression of RANKL on T cells
Osteoprotegrin (OPG) is a decoy receptor that binds membrane bound and soluble RANKL on activated T and B cells
Potassium channel blocker (Kaliotoxin) reduce the expression of RANKL on T cells
Osteoclast Precursor
Osteoclast Precursor
RANKRANK
T helper 2T helper 2
T cell
mRANKLmRANKL sRANKLsRANKL
CD4CD4B220B220 B cell
TRAP+Osteoclast
TRAP+Osteoclast
Bone Destruction
+ M-CSF+ M-CSF
Osteoprotegrin (OPG)
Potassium channel blocker (kaliotoxin)
ConclusionConclusion Th1 type response IFN-mediated protects
from disease progression.
Th2 type response IL-4 and IL10-mediated are inefficient at controlling microbial biofilm.
Interference with RANK - RANKL interaction of affects the degree of bone loss
Cytokines and lipid mediators may mediate systemic effects that increase the risk of preterm birth and/or low birth weight
Th1 type response IFN-mediated protects from disease progression.
Th2 type response IL-4 and IL10-mediated are inefficient at controlling microbial biofilm.
Interference with RANK - RANKL interaction of affects the degree of bone loss
Cytokines and lipid mediators may mediate systemic effects that increase the risk of preterm birth and/or low birth weight
Massimo Costalonga DMD, PhD DENT5301